The industry’s most powerful Omnichannel patient relationship management platform

A Trusted Leader in Enhanced Digital Patient Engagement
Meeting the Most Important Goals in Healthcare & Pharmaceutical
For over 30 years, we’ve helped healthcare facilities as well as pharmaceutical and life sciences companies communicate with patients to build trust, preserve care continuity, and enhance the patient experience — before, during, after, and between visits.
Each time you communicate with patients is an opportunity. The right patient engagement solution can check every box.
Meaningful, omnichannel interactions activate and engage patients from scheduling to intake, appointment and beyond, promoting better care outcomes.

End-to-end, automated workflows eliminate the manual burden associated with reaching patients and managing communication touchpoints.

By transforming patient outreach without adding to staff workload, healthcare facilities, pharmaceutical organizations, and life sciences companies can drive revenue-generating interactions.

Powered by Experience, Proven at Scale

Healthcare Facilities
Hospitals, health systems, physician practices, FQHCs, and CHCs have relied on our leading patient engagement solution for 30 years. We provide automated, omnichannel patient outreach that empowers these individuals to take control of their care, ultimately reducing no-shows, improving outcomes, and driving revenue — all without adding to staff workload. From the earliest phone and email appointment reminders in the 1990s to our new Iris AI-enabled conversational virtual assistant solution, TeleVox has continued to drive the patient engagement landscape by automating the patient journey from patient discovery through the visit and on through post visit.

Pharma, Payors & Life Sciences
TeleVox partners with pharmaceutical and life sciences companies to develop strategic disease state awareness, education, and vaccination reminders by reaching more patients through targeted communications that include postcards, text, email, and IVR.